Martin Fan, Ph.D.

ANALYST BIOGRAPHY

Martin Fan is a Vice President, Equity Research with over a decade of experience in drug discovery and analytics within the biotechnology sector. Before joining equity research, he held scientific and business development roles across both industry and academic institutions, with therapeutic focuses in oncology, vaccines and infectious diseases, and autoimmunity. His experience spans the bench to the boardroom—having worked as a bench scientist and later in business development—giving him a unique perspective on the biotech landscape. Prior to transitioning into research, Martin also worked in business consulting, where he specialized in translating complex clinical and scientific data for both specialist and generalist investors.

Martin earned his B.S. in Biochemistry from Washington University in St. Louis and holds a Ph.D. in Immunology from Harvard University.

ANALYST EDGE

Martin brings deep sector expertise in autoimmunity, allergies, and inflammation. His combined scientific and commercial background enables him to identify underappreciated risks and opportunities in early- and late-stage biotech companies. Having worked directly in biotech and consulted on strategy, Martin has a nuanced understanding of how science translates into pipeline value and a unique ability to communicate complex scientific insights in a way that resonates with diverse investor audiences.

COMPANIES UNDER COVERAGE